Table 4. ORs comparison between Group 1 (cervical cancer) and Group 3 (HPV negative with no cervical cancer).
Genotype | Group 1 (n = 285) | Group 3 (n = 318) | OR* (95% CI) | P | OR* (95% CI) | P |
No. (%) | No. (%) | |||||
GG | 247 (86.7) | 274 (86.2) | reference | 1.007(0.382–2.657) | 0.988 | |
GA | 30 (10.5) | 35 (11.0) | 0.932(0.554–1.567) | 0.790 | 0.791(0.321–2.747) | 0.908 |
AA | 8 (2.8) | 9 (2.8) | 0.993(0.376–2.618) | 0.988 | reference | |
GG+GA | 277 (97.2) | 309 (97.2) | reference | 1.000 (0.380–2.632) | 1.000 | |
AA | 8 (2.8) | 9 (2.8) | 1.000(0.380–2.634) | 1.000 | reference | |
GA+AA | 38 (13.3) | 44 (13.8) | reference | 0.944 (0.591–1.509) | 0.811 | |
GG | 247 (86.7) | 274 (86.2) | 1.059(0.663–1.692) | 0.811 | reference |
Note: *Data were calculated by multivariate regression analysis, adjusting for age and smoking status.